Izgia, K. Et Al. 2017. Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.17, no.3 , 404-414.

Izgia, K., Iskender, B., Sakalar, C., Arslanhan, A., Yuksek, E. H., Hizar, E., ... CANATAN, H.(2017). Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.17, no.3, 404-414.

Izgia, Kenan Et Al. "Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A," ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.17, no.3, 404-414, 2017

Izgia, Kenan Et Al. "Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A." ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.17, no.3, pp.404-414, 2017

Izgia, K. Et Al. (2017) . "Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A." ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.17, no.3, pp.404-414.

@article{article, author={Kenan Izgia Et Al. }, title={Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A}, journal={ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY}, year=2017, pages={404-414} }